
Parveen Sikri
About Parveen Sikri
Data last updated:
Parveen Sikri is a Director at Ikris Pharma Network Private Limited (since 2014), Director at Dotcom Pharma Private Limited (since 2019) and Designated Partner at Sattva Shilp Llp (since 2023). The companies operate in Business Outsourcing, Healthcare and Consumer Electronics & Durables. The 2 current companies with reported revenue have a combined latest revenue of ₹21.61 Cr; the largest is Ikris Pharma Network Private Limited at ₹21.61 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 13 Aug 2014 | 2014 | ₹21.61 Cr (FY 2025) | Active | |
| Director | 30 Jul 2019 | 2016 | ₹28,500 (FY 2024) | Active | |
| Designated Partner | 03 Aug 2023 | 2023 | Active |
Board colleagues of Parveen Sikri
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bharat Sikri | 06925711 | Ikris Pharma Network Private Limited , Dotcom Pharma Private Limited | Director |
| Samya Sikri | 10316656 | Sattva Shilp Llp | Designated Partner |
| Suresh Purohit | 08791021 | Sattva Shilp Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Parveen Sikri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Parveen Sikri
Parveen Sikri currently holds 3 directorships: Ikris Pharma Network Private Limited (Director, since 13 Aug 2014, revenue ₹21.61 Cr (FY 2025)); Dotcom Pharma Private Limited (Director, since 30 Jul 2019, revenue ₹28,500 (FY 2024)); Sattva Shilp Llp (Designated Partner, since 03 Aug 2023).
Parveen Sikri was first appointed on 13 Aug 2014 as Director at Ikris Pharma Network Private Limited. The most recent appointment on record is 03 Aug 2023 at Sattva Shilp Llp.
The 2 current companies of Parveen Sikri that report revenue have a combined latest revenue of ₹21.61 Cr: Ikris Pharma Network Private Limited ₹21.61 Cr (FY 2025); Dotcom Pharma Private Limited ₹28,500 (FY 2024).
The current boards of Parveen Sikri's companies include Bharat Sikri (Ikris Pharma Network Private Limited), Samya Sikri (Sattva Shilp Llp), Suresh Purohit (Sattva Shilp Llp).